Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT04432623
The BENeFiTS Trial in Beta Thalassemia Intermedia
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 5, 2020
Completion: Feb 28, 2026